W80 bil. Stillen market will heat up

Many major pharmaceutical manufacturers will rush to introduce the first version of Stillen capsule, one of Dong-A Pharmaceutical’s flagship products for treatment of gastritis, as the re-examination period of this medicine expired on June 11.

Stillen was developed by joint researches among the industry, academia and private laboratories in Korea and Dong-A invested a total of 18 billion won...